Saitohin polymorphism and executive dysfunction in schizophrenia

Neurological Sciences

Volumn 33, Issue 5, 2012, Pages 1051-1056

  Bosia, Marta ^a,b   Buonocore, Mariachiara ^a   Guglielmino, Carmelo ^a   Pirovano, Adele ^b   Lorenzi, Cristina ^a   Marcone, Alessandra ^a   Bramanti, Placido ^c   Cappa, Stefano F ^a,b   Aguglia, Eugenio ^d   Smeraldi, Enrico ^a,b   Cavallaro, Roberto ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Executive functions; Hypofrontality; Neurodegeneration; Saitohin; Schizophrenia; Tau protein

Indexed keywords

ADULT; ARTICLE; BRAIN DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; GENE; GENE FREQUENCY; GENE PRODUCT; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HYPOFRONTALITY; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NEUROPATHOLOGY; NEUROPATHY; SAITOHIN GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; WISCONSIN CARD SORTING TEST;

AGED; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TAU PROTEINS;

EID: 84869204608     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0893-9     Document Type: Article

References (31)

1. Conrad C, Vianna C, Schultz C, Thal DR, Ghebremedhin E, Lenz J et al (2004) Molecular evolution and genetics of the saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease. J Neurochem 89:179-188 (Pubitemid 38420687)
2. Verpillat P, Ricard S, Hannequin D, Dubois B, Bou J, Camuzat A et al (2002) Is the saitohin gene involved in neurodegenerative diseases? Ann Neurol 52:829-832 (Pubitemid 35403194)
3. Kwok JB, Teber ET, Loy C, Hallupp M, Nicholson G, Mellick GD et al (2004) Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann Neurol 55:329-334 (Pubitemid 38269584)
4. Gao L, Tse SW, Andreadis A, Conrad C (2005) Saitohin, which is nested in the tau locus and confers allele-specific susceptibility to several neurodegenerative diseases, interacts with peroxiredoxin 6. J Biol Chem 280:39268-39272 (Pubitemid 41713880)
5. De Silva R, Hope A, Pittman A, Weale ME, Morris HR, WoodNW et al (2003) Strong association of the saitohin gene Q7 variant with progressive supranuclear palsy. Neurology 61:407-409 (Pubitemid 36975979)
6. Jankovic N, Kecmanovic M, Dimitrijevic R, Markovic M, Dobricic V, Keckarevic D et al (2008) HD phenocopies-possible role of saitohin gene. Int J Neurosci 118:391-397
7. Levecque C, Elbaz A, Clavel J, Vidal JS, Amouyel P, Alpérovitch A et al (2004) Association of polymorphisms in the tau and saitohin genes with Parkinson's disease. J Neurol Neurosurg Psychiatry 75:478-480 (Pubitemid 38338783)
8. Conrad C, Vianna C, Freeman M, Davies P (2002) A polymorphic gene nested within an intron of the tau gene: Implications for Alzheimer's disease. Proc Natl Acad Sci USA 99:7751-7756 (Pubitemid 34568763)
9. Clark LN, Levy G, Tang MX, Santana H, Ciappa A, Tycko B et al (2003) The saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts. Neurosci Lett 347:17-20 (Pubitemid 36831096)
10. Cook L, Brayne CE, Easton D, Evans JG, Xuereb J, Cairns NJ et al (2002) No evidence for an association between saitohin Q7R polymorphism and Alzheimer's disease. Ann Neurol 52:690-691 (Pubitemid 35246881)
11. Streffer JR, Papassotiropoulos A, Kurosinski P, Signorelli A, Wollmer MA, Tsolaki M et al (2003) Saitohin gene is not associated with Alzheimer's disease. J Neurol Neurosurg Psychiatry 74:362-363 (Pubitemid 36259366)
12. Lorenzi C, Marcone A, Pirovano A, Marino E, Cordici F, Cerami C, Delmonte D, Cappa SF, Bramanti P, Smeraldi E (2010) Serotonin transporter and saitohin genes in risk of Alzheimer's disease and frontotemporal lobar dementia: Preliminary findings. Neurol Sci 31:741-749
13. Borroni B, Paghera B, Agosti C, Anchisi D, Perani D, Archetti S et al (2008) Tau haplotype influences cerebral perfusion pattern in frontotemporal lobar degeneration and related disorders. Acta Neurol Scand 117:359-366 (Pubitemid 351503331)
14. Borroni B, Grassi M, Agosti C, Alberici A, Premi E, Archetti S et al (2010) Establishing short-term prognosis in frontotemporal lobar degeneration spectrum: Role of genetic background and clinical phenotype. Neurobiol Aging 31(2):270-279
15. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubuleassociated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913-4917
16. Hong M, Lee VM (1997) Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272:19547-19553 (Pubitemid 27337756)
17. RappMA, Schnaider-BeeriM, PurhoitDP, ReichenbergA,McGurk SR, Haroutunian V, Harvey PD (2010) Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients. Schizophr Res 116:90-96
18. Costa E, Chen Y, Davis J, Dong E, Noh JS, Tremolizzo L et al (2002) Reelin and schizophrenia: A disease at the interface of the genome and the epigenome. Mol Interv 2:47-57
19. Guidotti A, Auta J, Davis M, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR et al (2000) Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study. Arch Gen Psychiatry 57:1061-1069
20. Bock HH, Herz J (2003) Reelin activates src family tyrosine kinases in neurons. Curr Biol 13:18-26 (Pubitemid 36080618)
21. Rice DS, Curran T (1999) Mutant mice with scrambled brains: Understanding the signaling pathways that control cell positioning in the CNS. Genes Dev 13:2758-2773
22. Liu WS, Pesold C, Rodriguez MA, Carboni G, Auta J, Lacor P et al (2001) Downregulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc Natl Acad Sci USA 98:3477-3482 (Pubitemid 32220870)
23. Schoder D, Hannequin D, Martinaud O, Opolczynski G, Guyant- Maréchal L, Le Ber I, Campion D (2010) Morbid risk for schizophrenia in first-degree relatives of people with frontotemporal dementia. Br J Psychiatry 197:28-35
24. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276 (Pubitemid 18039085)
25. Stratta P, Arduini L, Daneluzzo E, Rinaldi O, Di Genova A, Rossi A (2004) Relationship of good and poor Wisconsin Card Sorting Test performance to illness duration in schizophrenia: A crosssectional analysis. Psychiatry Res 121:219-227 (Pubitemid 37522175)
26. Cavallaro R, Cavedini P, Mistretta P, Bassi T, Angelone SM, Ubbiali A et al (2003) Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: A controlled, double dissociation study. Biol Psychiatry 54:437-443 (Pubitemid 37289450)
27. Ermoli E, Anselmetti S, Bechi M, Cocchi F, Smeraldi E, Cavallaro R (2005) Assessment of psychosis in schizophrenia: Neuropsychological profile of chronic schizophrenia. Clin Neuropsychiatry 2:243-249
28. Johansson A, Zetterberg H, Hakansson A, Nissbrandt H, Blennow K (2005) TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease. Neurodegener Dis 2:28-35 (Pubitemid 41158937)
29. Karlsgodt KH, Sanz J, van Erp TG, Bearden CE, Nuechterlein KH, Cannon TD (2009) Re-evaluating dorsolateral prefrontal cortex activation during working memory in schizophrenia. Schizophr Res 108:143-150
30. Brigman JL, Padukiewicz KE, Sutherland ML, Rothblat LA (2006) Executive functions in the heterozygous reeler mouse model of schizophrenia. Behav Neurosci 120:984-988
31. Gold J (1998) Schizophrenia and intellectual decline. Am J Psychiatry 155:1633-1634